Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC

Bacterium Induced to Resist Radiation Damage in the Lab

By BiotechDaily International staff writers
Posted on 30 Mar 2014
By exploiting the ability of an organism to evolve in response to punishment from a hostile environment, scientists have coaxed the bacterium Escherichia coli to drastically resist ionizing radiation, and at the same time, reveal the genetic mechanisms that make the feat possible.

The study, published March 4, 2014, in the online journal eLife, provides evidence that only several genetic mutations give E. coli the capacity to tolerate doses of radiation that would otherwise kill the microbe. The findings are important because they have implications for better determination of how organisms can resist radiation damage to cells and repair damaged DNA. “What our work shows is that the repair systems can adapt and those adaptations contribute a lot to radiation resistance,” said University of Wisconsin-Madison (USA) biochemistry Prof. Michael Cox, the senior author of the report.

Prof. Cox and his group, working with John R. Battista, a professor of biological sciences at Louisiana State University (Baton Rouge, USA), in earlier research demonstrated that E. coli could evolve to resist ionizing radiation by exposing cultures of the bacterium to the highly radioactive isotope cobalt-60. “We blasted the cultures until 99% of the bacteria were dead. Then we’d grow up the survivors and blast them again. We did that 20 times,” explained Prof. Cox.

The outcome was E. coli capable of enduring as much as four orders of magnitude more ionizing radiation, making them similar to Deinococcus radiodurans, a bacterium that lives in the desert found in the 1950s to be incredibly resistant to radiation. That bacterium is capable of surviving more than one thousand times the radiation dose that would kill a human. “Deinococcus evolved mainly to survive desiccation, not radiation,” Prof. Cox said, “so when conditions are right, it can repair damage very quickly and start growing again.”

Determining the molecular machinery that allows some organisms to survive what would otherwise be deadly doses of radiation is significant because the same bacterial processes that repairs DNA and protects cells in microbes exists in humans and other organisms. Although turning the new findings into application is in the distant future, the new findings could eventually contribute engineered microbes capable of helping clean radioactive waste sites or making probiotics that could aid patients undergoing radiation therapy for some cancers.

The new study showed that organisms can actively repair genetic damage from ionizing radiation. Before this new research, scientists believed the ability of cells to resist radiation originated mostly from their ability to detoxify the reactive oxygen molecules created by radiation within cells.

That passive detoxification approach, noted Dr. Cox, is in all probability working in tandem with active processes such as the mutations found by these investigators as well as other, yet-to-be-discovered mechanisms. “This extreme resistance we’re looking at is a complicated phenotype,” said Dr. Cox. “There are likely additional mechanisms buried in this data and we're working to pull those out.”

Related Links:

University of Wisconsin-Madison



Channels

Genomics/Proteomics

view channel
Image: The non-active drug is activated when it becomes localized at a site with excessive inflammation (Photo courtesy of Ben-Gurion University of the Negev).

Chimeric Drug Reduces Local Inflammation Without Causing General Immune Suppression

A novel anti-inflammatory drug is based on a chimeric molecule that avoids general immune suppression by being non-active when injected but is converted into an activate agent by leukocytes concentrated... Read more

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Business

view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.